Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugene A Woltering

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Surgery|October 30, 2012
Neurokinin A levels predict survival in patients with stage IV well differentiated small bowel neuroendocrine neoplasmsAnne E Diebold, J Philip Boudreaux, Yi-Zarn Wang, et al.
Cancers|January 18, 2020
Outcomes of Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs)Katharine Thomas, Brianne A Voros, Meghan Meadows-Taylor, et al.
Pancreas|November 1, 2005
Effect of octreotide LAR dose and weight on octreotide blood levels in patients with neuroendocrine tumorsEugene A Woltering, Paris M Mamikunian, Stanley Zietz, et al.
Journal of the American College of Surgeons|March 26, 2013
An extended phase II trial of iodine-125 methylene blue for sentinel lymph node identification in women with breast cancerWilliam W Harkrider, Anne E Diebold, Thomas Maloney, et al.
Pancreas|September 20, 2011
Validation of neurokinin a assays in the United States and EuropeParis Mamikunian, Joy E Ardill, Thomas M O'Dorisio, et al.
Journal of Medicinal Food|May 3, 2007
The safety and efficacy of a dietary herbal supplement and gallic acid for weight lossAndrew T Roberts, Corby K Martin, Zhijun Liu, et al.
The Journal of Surgical Research|May 6, 2004
The effect of drug dose and drug exposure time on the binding, internalization, and cytotoxicity of radiolabeled somatostatin analogsCatherine T Anthony, Susan Hughey, John Lyons, et al.
Journal of the American College of Surgeons|January 16, 2017
Aggressive Surgical Approach to the Management of Neuroendocrine Tumors: A Report of 1,000 Surgical Cytoreductions by a Single InstitutionEugene A Woltering, Brianne A Voros, David T Beyer, et al.
Pancreas|September 28, 2006
Validation of serum versus plasma measurements of chromogranin a levels in patients with carcinoid tumors: lack of correlation between absolute chromogranin a levels and symptom frequencyEugene A Woltering, Ruth S Hilton, Christy M Zolfoghary, et al.
Pancreas|July 29, 2010
NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus)Alexandria T Phan, Kjell Oberg, Junsung Choi, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Surgery|October 30, 2012
Neurokinin A levels predict survival in patients with stage IV well differentiated small bowel neuroendocrine neoplasmsAnne E Diebold, J Philip Boudreaux, Yi-Zarn Wang, et al.
Cancers|January 18, 2020
Outcomes of Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs)Katharine Thomas, Brianne A Voros, Meghan Meadows-Taylor, et al.
Pancreas|November 1, 2005
Effect of octreotide LAR dose and weight on octreotide blood levels in patients with neuroendocrine tumorsEugene A Woltering, Paris M Mamikunian, Stanley Zietz, et al.
Journal of the American College of Surgeons|March 26, 2013
An extended phase II trial of iodine-125 methylene blue for sentinel lymph node identification in women with breast cancerWilliam W Harkrider, Anne E Diebold, Thomas Maloney, et al.
Pancreas|September 20, 2011
Validation of neurokinin a assays in the United States and EuropeParis Mamikunian, Joy E Ardill, Thomas M O'Dorisio, et al.
Journal of Medicinal Food|May 3, 2007
The safety and efficacy of a dietary herbal supplement and gallic acid for weight lossAndrew T Roberts, Corby K Martin, Zhijun Liu, et al.
The Journal of Surgical Research|May 6, 2004
The effect of drug dose and drug exposure time on the binding, internalization, and cytotoxicity of radiolabeled somatostatin analogsCatherine T Anthony, Susan Hughey, John Lyons, et al.
Journal of the American College of Surgeons|January 16, 2017
Aggressive Surgical Approach to the Management of Neuroendocrine Tumors: A Report of 1,000 Surgical Cytoreductions by a Single InstitutionEugene A Woltering, Brianne A Voros, David T Beyer, et al.
Pancreas|September 28, 2006
Validation of serum versus plasma measurements of chromogranin a levels in patients with carcinoid tumors: lack of correlation between absolute chromogranin a levels and symptom frequencyEugene A Woltering, Ruth S Hilton, Christy M Zolfoghary, et al.
Pancreas|July 29, 2010
NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus)Alexandria T Phan, Kjell Oberg, Junsung Choi, et al.
Pageof 7